,subjsummary,subj,rel,obj,objsummary,ref
0,maois,monoamine oxidase inhibitors (maois),subset,antidepressants,antidepressants,"""monoamine oxidase inhibitor iproniazid be the first drug define as an antidepressant"""
1,maois,monoamine oxidase inhibitors (maois),associated with,"hepatotoxicity, hypertensive crisis",side effects,"""due to their irreversible inhibition of monoamine oxidase, moais have numerous side effect, such as hepatotoxicity and hypertensive crisis"""
2,maois,monoamine oxidase inhibitors (maois),specific efficacy in treating,depression with atypical features,atypical depression,"""maois have demonstrate specific efficacy in treat depression with atypical feature, such as reactive mood, reverse neuro-vegetative symptom, and sensitivity to rejection"""
3,ssris,selective serotonin reuptake inhibitors (ssris),first-line treatment,major depression,major depression,"""most guideline currently recommend ssris as the first-line treatment for patient with major depression"""
4,ssris,selective serotonin reuptake inhibitors (ssris),side effects,"sexual and digestive issues, irritability, anxiety, insomnia, headache",side effects,"""they have elicit different tolerance rate and side effect - mostly sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache"""
5,ssris,selective serotonin reuptake inhibitors (ssris),comparable to,tricyclic antidepressants (tcas),tcas,"""in most systematic review and meta-analysis, ssris have demonstrate comparable efficacy to tcas"""
6,snris,serotonin-norepinephrine reuptake inhibitors (snris),second-line treatment,patients not responding to ssris,ssri-resistant patients,"""clinical guideline commonly recommend prescribing snri to patient who do not respond to ssris"""
7,snris,serotonin-norepinephrine reuptake inhibitors (snris),comparable to,"selective serotonin reuptake inhibitors (ssris), tricyclic antidepressants (tcas)","ssris, tcas","""venlafaxine’s efficacy be comparable to that of tcas"""
8,ect,electroconvulsive therapy (ect),highly effective,resistant forms of depression,resistant depression,"""electroconvulsive therapy be the most effective somatic therapy for depression in some specific situation"""
9,resistant depression,resistant forms of depression,treats,"combination of medication, psychotherapy, somatic therapy",combination therapy,"""combine medication, psychotherapy, and somatic therapy remain the most effective way to manage resistant form of depression"""
0,mirtazapine,mirtazapine,properties,increases the availability of serotonin or norepinephrine and antagonizes serotoninergic subtype receptors,serotonin/norepinephrine availability & receptor antagonism,"mirtazapine and mianserin be tetracyclic compound believe to increase the availability of serotonin or norepinephrine (or both), at least initially. mirtazapine’s ability to antagonize serotoninergic subtype receptor, <5-ht2a> and <5-ht2c>, could also increase norepinephrine and dopamine release in cortical region."
1,mirtazapine,mirtazapine,comparable to,ssris,ssris,mirtazapine be about as effective as ssris.
2,vilazodone/vortioxetine,vilazodone and vortioxetine,benefits,produce less sexual dysfunction and benefits in depression-related cognitive impairment,less sexual dysfunction & cognitive benefits,"however, they appear to produce less sexual dysfunction and, in the specific case of vortioxetine, have particular benefit in depression-relate cognitive impairment."
3,antidepressants,different class of antidepressants,consistency,no significant difference in terms of efficacy,efficacy consistency,"in conclusion, no significant difference have be find between different class of antidepressants in terms of their efficacy."
4,citalopram/escitalopram/fluoxetine/sertraline/vortioxetine,"citalopram, escitalopram, fluoxetine, sertraline, and vortioxetine",more tolerable,compare to other antidepressants,higher tolerability,"concern the acceptability of these drugs, citalopram, escitalopram, fluoxetine, sertraline, and vortioxetine have be deem more tolerable than other antide- pressant."
5,ketamine,ketamine,treats,treatment-resistant unipolar and bipolar depression and acute suicidal ideation,depression & suicidal ideation,"ketamine have very quick effect on resistant unipolar (and, possibly, bipolar) depression and acute suicidal ideation."
6,ketamine,ketamine,side effects,"dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms",various side effects,"common adverse effect of ketamine include dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms."
7,ketamine,ketamine,not effective,as a long-term solution due to potential for neurotoxicity and drug dependence,long-term solution concerns,"such adverse effect tend to be brief in acute, low-dose treatment, whereas prolonged exposure may predispose patient to neurotoxicity and drug dependence."
8,cbt/ipt,cognitive-behavioral therapy (cbt) and interpersonal therapy (ipt),overview,psychotherapeutic methods for mild to moderate major depressive disorder,mild/moderate mdd treatment,"depression-focused psychotherapy be typically consider the initial treatment method for mild to moderate mdd. base on significant clinical evidence, two specific psychotherapeutic methods be recommend: cognitive-behavioral therapy (cbt) and interpersonal therapy (ipt)."
0,cbt,cognitive-behavioral therapy,first-line treatment,mild to moderate major depressive disorder,mdd,"cbt, like cbt, be a first-line treatment for mild to moderate major depressive episode in adult; it be also a well-establish intervention for adolescent with depression [25]."
1,ipt,interpersonal therapy,first-line treatment,mild to moderate major depressive disorder,mdd,"ipt, like cbt, be a first-line treatment for mild to moderate major depressive episode in adult; it be also a well-establish intervention for adolescent with depression [25]."
2,exercise,physical exercise,definition,a complementary intervention for depression aimed to alleviate symptoms and prevent relapse,complementary intervention,"most guideline for treat depression, include the national institute for health and care excellence, the american psychiatric association, and the royal australian and new zealand college of psychiatrist, recommend that depress patient perform regular physical activity to alleviate symptom and prevent relapse [104]."
3,mft,marital and family therapy,treats,aspects of depression,depression,marital and family therapy (mft) be effective in treat some aspect of depression.
4,pst,problem-solve therapy,comparable to,other psychotherapeutic methods,psychotherapeutic methods,"pst have be use in different clinical situation, like prevent depression among the elderly and treat patient with mild depressive symptom, especially in primary care. despite its small effect size, pst be comparable to other psychotherapeutic method use to treat depression [88,90]."
5,ect,electroconvulsive therapy,highly effective,depression,depression,"ect be arguably the most effective treatment modality in psychiatry, and its superiority over pharmacotherapy for major unipolar depression be widely support [110]."
6,st,supportive therapy,overview,"utilizes sympathetic listening, emotionally attuned listen, empathic paraphrasing to improve patient's self-esteem and adaptive coping skills",therapy approach,"although st be not as well-structure or well-evaluate as cbt or ipt, it be still commonly use to support depressed patient. in addition to sympathetic listening and express concern for the patient’s problem, st require emotionally attuned listen, empathic paraphrasing, explain the nature of the patient’s suffering, and reassure and encourage they."
7,mbct,mindfulness based cognitive therapy,benefits,patients at high risk of relapse,high risk patients,"thus, mbct be a potential alternative to reduce, or even stop, antidepressant treatment without increase the risk of depressive recurrence, especially for patient at a high risk of relapse (i.e., patient with more than two previous episode and patient who have experience childhood abuse or trauma) [102]."
8,psycho-education,psycho-education,goal,"improve clinical course, treatment adherence, and psychosocial function in patients with depression",clinical improvement,"many study have highlight the role of psycho-education in improve the clinical course, treatment adherence, and psychosocial function in patient with depression [103]."
0,tdcs,transcranial direct current stimulation (tdcs),associated with,remote supervised treatment,remote treatment,"tdcs, as a relatively simple and portable technology, be well-suited for remote supervised treatment and assessment at home."
1,vns,vagus nerve stimulation (vns),definition,a therapeutic method using implanted pacemaker to treat resistant depression,therapeutic method,vns involves the implantation of a pacemaker under the collarbone that be connect to an electrode surround the left vagus nerve.
2,vns,vagus nerve stimulation (vns),subset,somatic interventions for depression,somatic interventions,"furthermore, somatic intervention for depression need to be regularly assess and integrate into psychiatrist’s therapeutic arsenal."
3,ect,electroconvulsive therapy (ect),widely used,treatment for depression,depression treatment,ect remain the most document and effective method in this category.
4,rtms,repetitive transcranial magnetic stimulation (rtms),comparable to,ect for treating depression,ect,"rtms be an interesting technique as well, as it offer a well-tolerated profile."
5,phototherapy,phototherapy,treats,seasonal and non-seasonal depression,seasonal depression,"importantly, this treatment method be effective both for those with seasonal and non-seasonal depression."
6,antidepressants,antidepressants,treatment options,all depression,depression,"the three principal method available to caregiver be antidepressants, specifically structure psychotherapy, and somatic approach."
7,depression pharmacotherapy,depression pharmacotherapy,associated with,gamma-aminobutyric acid regulation and glutamate transmission,neurotransmitter regulation,research on depression pharmacotherapy continue to examine new molecule implicate in gamma-aminobutyric acid regulation and glutamate transmission.
8,somatic interventions,somatic interventions for depression,overview,"combination of medication, psychotherapy, and somatic therapy",combination therapy,"combination of medication, psychotherapy, and somatic therapy remain the most effective way to manage resistant form of depression."
0,ketamine,ketamine,treats,treatment-resistant depression,trd,ketamine for treatment-resistant depression: recent development and clinical applications. [pmid: 27053196 doi: 10.1136/eb-2016-102355]
1,intranasal esketamine,intranasal esketamine,form of,ketamine,ketamine,intranasal esketamine: a novel drug for treatment-resistant depression. [pmid: 32729898 doi: 10.1093/ajhp/zxaa191]
2,trd,treatment-resistant depression,associated with,major depressive disorder,mdd,intranasal esketamine: from origin to future implications in treatment-resistant depression. [pmid: 33647726 doi: 10.1016/j.jpsychires.2021.02.020]
3,nefazodone,nefazodone,side effects,hepatobiliary transport inhibition,hepatobiliary inhibition,inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone. [pmid: 16410371 doi: 10.1093/toxsci/kfj095]
4,vortioxetine,vortioxetine,treats,major depressive disorder,mdd,vortioxetine: a novel antidepressant for the treatment of major depressive disorder. [pmid: 30457395 doi: 10.1080/17460441.2019.1546691]
5,bupropion,bupropion,more effective,ssris for major depressive disorder with high levels of anxiety (anxious depression),anxious depression,efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pool analysis of 10 studies. [pmid: 18605812 doi: 10.4088/jcp.v69n0812]
6,mirtazapine,mirtazapine,comparable to,selective serotonin reuptake inhibitors for the treatment of major depressive disorder,ssris,a meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. [pmid: 18308801 doi: 10.1177/0269881107083808]
7,ssris,selective serotonin reuptake inhibitors,less effective,mirtazapine for the treatment of major depressive disorder,mirtazapine,a meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. [pmid: 18308801 doi: 10.1177/0269881107083808]
0,ect,electroconvulsive therapy,treats,treatment-resistant major depression,trmd,"""electroconvulsive therapy and risk of dementia - a nationwide cohort study in taiwan."""
1,ect,electroconvulsive therapy,associated with,psychiatric readmission reduction,readmission reduction,"""association of electroconvulsive therapy with psychiatric readmission in us hospital."""
2,ect,electroconvulsive therapy,side effects,in-hospital mortality risk,mortality risk,"""in-hospital mortality among electroconvulsive therapy recipients: a 17 -year nationwide population-based retrospective study."""
3,rtms,repetitive transcranial magnetic stimulation,treats,major depressive disorder,mdd,"""effectiveness of psychoeducation for depression: a systematic review."""
4,exercise,exercise,treats,severe major depression,smd,"""portuguese and brazilian guideline for the treatment of depression: exercise as medicine."""
5,rtms,repetitive transcranial magnetic stimulation,associated with,quality of life improvement,qol improvement,"""effect of psychotherapy for depression on quality of life: meta-analysis."""
6,psychotherapy,psychotherapy,treats,depression,all depression,"""training with psychoeducation for depression: a systematic review."""
7,vns,vagus nerve stimulation,treats,treatment-resistant depression,trd,"""therapeutic modality for treatment resistant depression: focus on vagal nerve stimulation and ketamine."""
8,dbs,deep brain stimulation,treats,treatment-resistant depression,trd,"""deep brain stimulation for treatment-resistant depression."""
9,light therapy,light therapy,treats,mood disorders,mood disorders,"""the efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence."""
10,ect,electroconvulsive therapy,symptom,improvement in major depression,improvement in md,"""improvement after two sessions of electroconvulsive therapy predicts final remission in in-patients with major depression."""
0,mdd,major depressive disorder,definition,unipolar major depression,unipolar major depression,"we include only randomise control trial that compare any of the follow 12 new - generation antidepressant ( bupropion , citalopram , duloxetine , escitalopram , ﬂuoxetine , ﬂuvoxamine , milnacipran , mirtazapine , paroxetine , reboxetine , sertraline , and venlafaxine ) as monotherapy in the acute - phase treatment of adult with unipolar major depression."
1,"mirtazapine, escitalopram, venlafaxine, sertraline","mirtazapine, escitalopram, venlafaxine, sertraline",more effective,"duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","mirtazapine, escitalopram, venlafaxine, and sertraline be significantly more efficacious than duloxetine (odd ratio [or] 1·39, 1·33, 1·30 and 1·27, respectively), fluoxetine (1·37, 1·32, 1·28, and 1·25, respectively), fluvoxamine (1·41, 1·35, 1·30, and 1·27, respectively), paroxetine (1·35, 1·30, 1·27, and 1·22, respectively), and reboxetine (2·03, 1·95, 1·89, and 1·85, respectively)."
2,reboxetine,reboxetine,less effective,all other tested antidepressants,other antidepressants,reboxetine be significantly less efficacious than all the other antidepressant tested.
3,"escitalopram, sertraline",escitalopram and sertraline,benefits,fewer discontinuations,fewer discontinuations,"escitalopram and sertraline show the good profile of acceptability, leading to significantly fewer discontinuations than do duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine."
4,sertraline,sertraline,first-line treatment,moderate to severe major depressive disorder in adults,mdd in adults,"sertraline might be the best choice when starting treatment for moderate to severe major depression in adults because it has the most favourable balance between benefits, acceptability, and acquisition cost."
5,dosage comparability,comparability of dosage,definition,assessment of equivalent dosing ranges among new-generation antidepressants,dosing equity,"in addition to internal and external validity, we assess the comparability of dosage."
6,antidepressants,antidepressants,example,"bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine",12 new-generation antidepressants,"we include only randomise control trial that compare any of the follow 12 new - generation antidepressant (bupropion , citalopram , duloxetine , escitalopram , fluoxetine , fluvoxamine , milnacipran , mirtazapine , paroxetine , reboxetine , sertraline , and venlafaxine) as monotherapy in the acute - phase treatment of adult with unipolar major depression."
0,escitalopram,escitalopram,more effective,"citalopram, reboxetine, paroxetine, fluoxetine, fluvoxamine","citalopram, reboxetine, paroxetine, fluoxetine, fluvoxamine","""efficacy favour escitalopram over citalopram; citalopram over reboxetine and paroxetine; mirtazapine over fluoxetine and venlafaxine; sertraline over fluoxetine; and venlafaxine over fluoxetine and fluvoxamine."""
1,mirtazapine,mirtazapine,more effective,"fluoxetine, venlafaxine","fluoxetine, venlafaxine","""efficacy favour escitalopram over citalopram; citalopram over reboxetine and paroxetine; mirtazapine over fluoxetine and venlafaxine; sertraline over fluoxetine; and venlafaxine over fluoxetine and fluvoxamine."""
2,sertraline,sertraline,more effective,fluoxetine,fluoxetine,"""efficacy favour escitalopram over citalopram; citalopram over reboxetine and paroxetine; mirtazapine over fluoxetine and venlafaxine; sertraline over fluoxetine; and venlafaxine over fluoxetine and fluvoxamine."""
3,venlafaxine,venlafaxine,more effective,"fluoxetine, fluvoxamine","fluoxetine, fluvoxamine","""efficacy favour escitalopram over citalopram; citalopram over reboxetine and paroxetine; mirtazapine over fluoxetine and venlafaxine; sertraline over fluoxetine; and venlafaxine over fluoxetine and fluvoxamine."""
4,fluoxetine,fluoxetine,less well tolerated,reboxetine,reboxetine,"for dropout, fluoxetine was well tolerated than reboxetine"
5,citalopram,citalopram,less well tolerated,sertraline,sertraline,"for dropout, citalopram than sertraline"
6,duloxetine,duloxetine,less well tolerated,"escitalopram, sertraline","escitalopram, sertraline","in terms of acceptability, duloxetine and paroxetine were less well tolerated than escitalopram and sertraline"
7,paroxetine,paroxetine,less well tolerated,"escitalopram, sertraline","escitalopram, sertraline","in terms of acceptability, duloxetine and paroxetine were less well tolerated than escitalopram and sertraline"
8,fluvoxamine,fluvoxamine,less well tolerated,"citalopram, escitalopram, sertraline","citalopram, escitalopram, sertraline","fluvoxamine less well tolerated than citalopram, escitalopram, and sertraline"
9,venlafaxine,venlafaxine,less well tolerated,escitalopram,escitalopram,venlafaxine less well tolerated than escitalopram
10,reboxetine,reboxetine,less effective,all the other 11 antidepressant,all other antidepressants,reboxetine was significantly less efficacious than all the other 11 antidepressants.
0,reboxetine,reboxetine,not effective,major depression,major depression,"therefore, reboxetine should not be use as a routine first-line acute treatment for major depression."
1,mirtazapine,mirtazapine,more effective,"duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine",several antidepressants,"in terms of response, mirtazapine, escitalopram, venlafaxine, and sertraline be more efficacious than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine."
2,escitalopram,escitalopram,treats,major depression,major depression,"here, we do not investigate important outcome, such as side-effect, toxic effect, discontinuation symptom, and social functioning. however, the most important clinical implication of the result be that escitalopram and sertraline might be the good choice when start a treatment for moderate to severe major depression because they have the good possible balance between efficacy and acceptability."
3,sertraline,sertraline,highly effective,major depression,major depression,our analysis suggest that sertraline be better than other new-generation drug in terms of efficacy and acceptability
4,escitalopram,escitalopram,more effective,other new-generation antidepressants,other antidepressants,"in terms of acceptability, escitalopram, sertraline, citalopram, and bupropion be well tolerate than other new-generation antidepressant."
5,reboxetine,reboxetine,least effective,other antidepressants,other antidepressants,"in terms of acceptability, reboxetine be the least tolerate agent among the 12 antidepressant and be significantly less effective than all the other 11 drug."
0,milnacipran,milnacipran,definition,a new serotonin and noradrenaline reuptake inhibitor,snri,"""milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability."""
1,venlafaxine,venlafaxine,definition,compares with selective serotonin reuptake inhibitors,ssris,"""efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis."""
2,second-generation antidepressants,second-generation antidepressants,treats,major depressive disorder,mdd,"""efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder."""
3,fluoxetine,fluoxetine,comparable to,other antidepressants,antidepressants,"""are all antidepressants really the same? the case of fluoxetine: a systematic review."""
4,antidepressants,antidepressants that combine serotonergic and noradrenergic mechanisms of action,more effective,selective serotonin reuptake inhibitors in treating major depressive disorder,ssris,"""are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? a meta-analysis of studies of newer agents."""
5,venlafaxine,venlafaxine,side effects,sexual dysfunction,sexual dysfunction,"""lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder."""
6,bupropion xl,bupropion xl,side effects,sexual functioning,sexual functioning,"""a comparison of the effect on sexual functioning of bupropion xl, escitalopram, and placebo in patients with major depression."""
0,anxious depression,anxious depression,subset,major depressive disorder,mdd,about half of outpatients with major depressive disorder also have clinically meaningful levels of anxiety
1,anxious depression,anxious depression,associated with,poor acute outcome than nonanxious depression following antidepressant treatment,poor outcomes,anxious depression is associated with poorer acute outcomes than nonanxious depression following antidepressant treatment
2,mdd,major depressive disorder,symptom,"anxiety, nervousness, and somatic correlates of these states",anxiety symptoms,"patients with major depressive disorder often also suffer from anxiety, nervousness, and the somatic correlates of these states"
3,anxious depression,anxious depression,more common than,nonanxious depression,nonanxious depression,"in lifetime comorbidity rates of anxiety disorders among outpatients with major depression, anxious depression is reported"
4,anxious depression,anxious depression,results,remission significantly less likely and longer to occur,longer remission times,remission was significantly less likely and took longer to occur in patients with anxious depression than in those with nonanxious depression
5,citalopram,citalopram,first-line treatment,major depressive disorder in star*d level 1,mdd in star*d l1,"a total of 2,876 adult outpatients with major depressive disorder received citalopram in level 1 of star*d"
6,side effects,side effects,associated with,anxious depression treatment with citalopram in star*d,anxious depression treatment,"ratings of side effect frequency, intensity, and burden, as well as the number of serious adverse events, were significantly greater in the anxious depression group"
0,anxious depression,anxious depression,more common than,nonanxious depression,nonanxious depression,"anxious depression be significantly more common than nonanxious depression among african americans than in other racial/ethnicgroup ; among hispanic than non - hispanic ; amongthose see in primary care setting than those in psychiatric care setting ; among those who be unemployed thanthose who be employ ; among those who be mar - rie, divorced, or widow than among those who hadnever marry ; and among those with less education, those with public insurance, and those with less income."
1,anxious depression,anxious depression,associated with,"greater likelihood of reported suicidal ideation, personal history of attempted suicide, family history of drug abuse","suicidal ideation, attempted suicide, drug abuse","anxious depression be associated with a great likelihood of reported suicidal ideation on the ham - d, a personal history of attempted suicide, and a family history of drug abuse."
2,anxious depression,anxious depression,associated with,more medical comorbidity,medical comorbidity,patient with anxious depression be significantly more likely than those with nonanxious depression to have more medical comorbidity.
3,citalopram,citalopram,treats,major depressive disorder,major depressive disorder,"overall, they also take long to remit. this association between anxious depression and poor treatment outcome with citalopram hold true regardless of how we define anxious depression."
4,anxious depression,anxious depression,results,lower remission and response rates with citalopram treatment,lower remission/response rates,"remission rate be significantly lower in patient with anxious depression, according to both the ham - d criterion (22.2 % versus 33.4 % ) and the qids - sr criterion (27.5 % versus 38.9 %). response rates were also significantly lower for patient with anxious depression (41.7 % versus 52.8 %)."
5,anxious depression,anxious depression,associated with,"greater frequency, intensity, and burden of side effects than nonanxious depression",greater side effects,"the anxious depression group have greater frequency, intensity, and burden of side effects than the nonanxious depression group, as well as more serious adverse event."
6,anxious depression,anxious depression,associated with,more psychiatric and general medical comorbidities,psychiatric/medical comorbidities,"individual with anxious major depressive disorder be more likely to meet psychiatric diagnostic screening questionnaire criterion for generalize anxiety disorder, panic disorder, social phobia, obsessive-compulsive disorder, posttraumatic stress disorder, agoraphobia, hypochondriasis, and somatoform disorder and to have a greater overall number of comorbid axis i condition."
0,anxious depression,anxious depression,more common than,nonanxious depression,nonanxious depression,"anxious depression --> more common than -> nonanxious depression -> in -> african american group, hispanics, primary care patients, unemployed, married then divorced/widowed, less, education, public insurance, lower-income"
1,anxious depression,anxious depression,associated with,higher side effect burden,higher side effect burden,"side effect frequency, intensity, and burden in level 1 be great among patient with anxious depression thanamong those with nonanxious depression"
2,anxious depression,anxious depression,associated with,serious adverse events,serious adverse events,"as be serious adverse event, include those of a psychiatric nature"
3,anxious depression,anxious depression,less effective,antidepressant treatment,antidepressant treatment,patient with this subtype be less likely to achieve remission than those with nonanxious depression after antidepressant treatment
4,remission,remission,benefits,patients without residual symptoms,patients without residual symptoms,this study have several implication for the recognition and diagnosis ofanxious depression
5,anxious depression,anxious depression,definition,subtype of major depressive disorder,subtype of mdd,our result also suggestthe need for additional emphasis on the measurement ofsymptom of anxiety during the acute management ofpatient with major depression
6,ham-d,ham-d,definition,measure severity of anxiety symptoms,measure of anxiety symptoms,our definition of anxious depression be base onthe severity of anxiety symptom as measure by the ham - d anxiety / somatization factor
7,citalopram,citalopram,treats,anxious depression,anxious depression,both time in treatment and time on the final citalopram dosage be significantly low in the anxiousthan in the nonanxious depression group
8,benzodiazepine,benzodiazepine,treats,worsening of insomnia and nervousness in anxious depression,insomnia and nervousness,"a benzodiazepine be prescribe, which bring about a signiﬁcant improvement in her insomnia and agitation"
9,anxious depression,anxious depression,associated with,physical symptom sensitivity,physical symptom sensitivity,perhaps patient whose illness include anxious feature be more sensitive to somatic change occur during antidepressant treatment
